Predicting the future for people with lung cancer
- 1 August 2008
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 14 (8) , 812-813
Abstract
A large multicenter study shows that lung adenocarcinomas have messenger RNA expression signatures that greatly add to the use of clinical data in predicting an individual's survival ( pages 822–827 ).Keywords
This publication has 12 references indexed in Scilit:
- Detection of Mutations inEGFRin Circulating Lung-Cancer CellsNew England Journal of Medicine, 2008
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- New molecularly targeted therapies for lung cancerJournal of Clinical Investigation, 2007
- Tumor mRNA Expression Profiles Predict Responses to ChemotherapyJournal of Clinical Oncology, 2007
- Personalized Medicine and Proteomics: Lessons from Non-Small Cell Lung CancerJournal of Proteome Research, 2007
- A 25-Signal Proteomic Signature and Outcome for Patients With Resected Non–Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2007
- The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer CellsNew England Journal of Medicine, 2007
- Hit 'Em Where They Live: Targeting the Cancer Stem Cell NicheCancer Cell, 2007
- Pharmacogenomics: bench to bedsideNature Reviews Drug Discovery, 2004